Green University of Michigan Professor Emeritus None None None None None None Paul A. Heidenreich Stanford VA Palo Alto Health Care System Professor of Medicine None None None None None None P. Michael Ho VA Eastern Colorado Health Care System University of Colorado School of Medicine Associate Professor of Medicine Anthem, Inc. Janssen Pharmaceuticals, Inc Premier, Inc. Telligen* None None None None None Corrine Y. Jurgens Stony Brook University Associate Professor None None None None None None Marjorie L. King Helen Hayes Hospital None None None None None None Dharam J. Kumbhani UT Southwestern Medical Center Assistant Professor of Medicine None None None None None None Samir Pancholy The Wright Center for Graduate Medical Education None Medtronic Pfizer Terumo Medical Duke Clinical Research Institute Odyssey Outcomes Trial None None This table represents the relationships of committee members with industry and other entities that were reported by authors to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity, or ownership of $5000 or more of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person s gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. 